- Home
- RDY vs MBLY Comparison
RDY vs MBLY Comparison
Compare RDY & MBLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- MBLY
- Stock Information
- Founded
- RDY 1984
- MBLY 1999
- Country
- RDY India
- MBLY Israel
- Employees
- RDY N/A
- MBLY N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- MBLY Computer Software: Prepackaged Software
- Sector
- RDY Health Care
- MBLY Technology
- Exchange
- RDY Nasdaq
- MBLY Nasdaq
- Market Cap
- RDY 11.6B
- MBLY 10.9B
- IPO Year
- RDY N/A
- MBLY 2022
- Fundamental
- Price
- RDY $13.88
- MBLY $12.48
- Analyst Decision
- RDY Strong Buy
- MBLY Buy
- Analyst Count
- RDY 1
- MBLY 17
- Target Price
- RDY $16.90
- MBLY $19.44
- AVG Volume (30 Days)
- RDY 1.1M
- MBLY 4.7M
- Earning Date
- RDY 10-24-2025
- MBLY 10-23-2025
- Dividend Yield
- RDY 0.51%
- MBLY N/A
- EPS Growth
- RDY 9.95
- MBLY N/A
- EPS
- RDY 0.79
- MBLY N/A
- Revenue
- RDY $3,851,623,984.00
- MBLY $1,938,000,000.00
- Revenue This Year
- RDY $6.29
- MBLY $15.48
- Revenue Next Year
- RDY $2.61
- MBLY $7.59
- P/E Ratio
- RDY $17.55
- MBLY N/A
- Revenue Growth
- RDY 14.10
- MBLY 7.61
- 52 Week Low
- RDY $12.26
- MBLY $11.58
- 52 Week High
- RDY $16.17
- MBLY $22.51
- Technical
- Relative Strength Index (RSI)
- RDY 49.14
- MBLY 37.53
- Support Level
- RDY $13.37
- MBLY $12.26
- Resistance Level
- RDY $13.52
- MBLY $13.10
- Average True Range (ATR)
- RDY 0.24
- MBLY 0.44
- MACD
- RDY 0.02
- MBLY -0.05
- Stochastic Oscillator
- RDY 49.31
- MBLY 13.28
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.